Harvard Heart Letter

New alternatives to warfarin

New prescriptions for novel anticoagulants now outnumber new prescriptions for warfarin. The new drugs are safer and at least as effective. They may be the best initial therapy for atrial fibrillation, but those now doing well on warfarin need not switch.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In